SCHEMBL5060799

SCHEMBL5060799

CN(C)CC/C=C1\c2ccccc2COc2cc(CC(=O)O)ccc21

nearest known ligand 0.85

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH1 P35367 5/20 0.85
LMNA P02545 2/20 0.85
PARP1 P09874 1/20 0.67
KCNH2 Q12809 2/20 0.66
HTR2B P41595 2/20 0.66
ALDH1A1 P00352 2/20 0.66
SLC22A1 O15245 1/20 0.66
CHRM2 P08172 1/20 0.66
CHRM4 P08173 1/20 0.66
HTR1A P08908 1/20 0.66
CHRM5 P08912 1/20 0.66
ADRA2A P08913 1/20 0.66
CHRM1 P11229 1/20 0.66
DRD2 P14416 1/20 0.66
ADRA2B P18089 1/20 0.66
ADRA2C P18825 1/20 0.66
CHRM3 P20309 1/20 0.66
DRD1 P21728 1/20 0.66
DRD4 P21917 1/20 0.66
DRD5 P21918 1/20 0.66

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5060800 1.00 HRH1 (0.85) HRH1LMNAPARP1KCNH2HTR2B
Olopatadine SCHEMBL1649764 0.92 HRH1 (1.00) HRH1LMNAPARP1KCNH2HTR2B
Olopatadine SCHEMBL29359369 0.92 HRH1 (1.00) HRH1LMNAPARP1KCNH2HTR2B
Olopatadine SCHEMBL4669 0.92 HRH1 (1.00) HRH1LMNAPARP1KCNH2HTR2B
Olopatadine SCHEMBL4668 0.92 HRH1 (1.00) HRH1LMNAPARP1KCNH2HTR2B
Olopatadine SCHEMBL29517420 0.92 HRH1 (1.00) HRH1LMNAPARP1KCNH2HTR2B
Olopatadine SCHEMBL694414 0.91 HRH1 (0.98) HRH1LMNAPARP1KCNH2HTR2B
Olopatadine SCHEMBL122589 0.91 HRH1 (0.98) HRH1LMNAPARP1KCNH2ALDH1A1
Olopatadine SCHEMBL23213 0.91 HRH1 (0.98) HRH1LMNAPARP1KCNH2ALDH1A1
Olopatadine SCHEMBL5324205 0.91 HRH1 (0.98) HRH1LMNAPARP1KCNH2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080139531-A1 USE OF CONNECTIVE TISSUE MAST CELL STABILIZERS TO FACILITATE OCULAR SURFACE RE-EPITHELIZATION AND WOUND REPAIR ALCON MANUFACTURING LTD. (US) 2008-06-12 US claimed
US-20080139531-A1 USE OF CONNECTIVE TISSUE MAST CELL STABILIZERS TO FACILITATE OCULAR SURFACE RE-EPITHELIZATION AND WOUND REPAIR ALCON MANUFACTURING LTD. (US) 2008-06-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080139531-A1 USE OF CONNECTIVE TISSUE MAST CELL STABILIZERS TO FACILITATE OCULAR SURFACE RE-EPITHELIZATION AND WOUND REPAIR CMA1, LTK, KIT HRH1 35/4885LMNA 3550/4885PARP1 1279/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.